doi: 10.1016/j.toxicon.2012.04.059 Sousa, Silmara R., Ragnarsson, Lotten, Vetter, Irina, Herzig, Volker, King, Glenn F
The phase 2 trial results, published in the New England Journal of Medicine in June 2023, didn't just demonstrate efficacythey shattered existing paradigms about the upper limits of pharmacological weight loss [8]
So, Ellen, this conversation couldn't be timelier
Recent research has found that Palmatine improves liver fibrosis by ameliorating GM dysbiosis in fibrotic rats, increasing the abundance of beneficial bacteria (such as Lactobacillus reuteri and Lactobacillus murinus) to enhance intestinal barrier function, and inhibiting hepatic inflammatory factors (LPS, TNF-, IL-6, and IL-1) [140]